GENET-news
To stay informed you can subscribe to the GENET-news list.
2007-06-25 | permalink
Future of biopharming in NZ still too early to tell
A Lincoln University study says it is too early to forecast what economic benefits - if any - are to be gained from New Zealand establishing a commercial biopharming industry. Biopharming - the production of pharmaceuticals compounds from genetically modified crops and livestock – is touted by some as an emerging success story in both agriculture and the pharmaceutical industry. Its advocates say biopharming has the potential to dramatically cut the cost of manufacturing compounds used in medicine, food manufacturing and dietary supplements.
Overview
News
2007-06-25 | permalink
Future of biopharming in NZ still too early to tell
A Lincoln University study says it is too early to forecast what economic benefits - if any - are to be gained from New Zealand establishing a commercial biopharming industry. Biopharming - the production of pharmaceuticals compounds from genetically modified crops and livestock – is touted by some as an emerging success story in both agriculture and the pharmaceutical industry. Its advocates say biopharming has the potential to dramatically cut the cost of manufacturing compounds used in medicine, food manufacturing and dietary supplements.
GENET-news & GENET-forum
GENET-news is providing a daily news service on a range of topics regarding genetic engineering. We are screening the worldwide English news, press releases and other publications to provide you with a strategic selection of information. GENET-news enables you to stay informed about all aspects of the global controversy around GE technologies and GE organisms. You can subscribe by 
email.
The GENET-forum list provides you with additional background information and more voluminous reports. It is only open for GENET members. Please contact the coordinator for membership and subscription.